These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9266979)

  • 1. GB virus C E2 glycoprotein: expression in CHO cells, purification and characterization.
    Surowy TK; Leary TP; Carrick RJ; Knigge MF; Pilot-Matias TJ; Heynen C; Gutierrez RA; Desai SM; Dawson GJ; Mushahwar IK
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1851-9. PubMed ID: 9266979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors.
    Tacke M; Schmolke S; Schlueter V; Sauleda S; Esteban JI; Tanaka E; Kiyosawa K; Alter HJ; Schmitt U; Hess G; Ofenloch-Haehnle B; Engel AM
    Hepatology; 1997 Dec; 26(6):1626-33. PubMed ID: 9398008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker.
    Pilot-Matias TJ; Carrick RJ; Coleman PF; Leary TP; Surowy TK; Simons JN; Muerhoff AS; Buijk SL; Chalmers ML; Dawson GJ; Desai SM; Mushahwar IK
    Virology; 1996 Nov; 225(2):282-92. PubMed ID: 8918914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ELISA for detection of antibodies to the E2 protein of GB virus C.
    Dille BJ; Surowy TK; Gutierrez RA; Coleman PF; Knigge MF; Carrick RJ; Aach RD; Hollinger FB; Stevens CE; Barbosa LH; Nemo GJ; Mosley JW; Dawson GJ; Mushahwar IK
    J Infect Dis; 1997 Feb; 175(2):458-61. PubMed ID: 9203673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody to GBV-C second envelope glycoprotein (anti-GBV-C E2): is it a marker for immunity?
    Hassoba HM; Terrault NA; el-Gohary AM; Scheffel C; Jou C; Brackett J; Hunt J; Lou SC; Wright TL
    J Med Virol; 1997 Dec; 53(4):354-60. PubMed ID: 9407383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection.
    Tillmann HL; Heringlake S; Trautwein C; Meissner D; Nashan B; Schlitt HJ; Kratochvil J; Hunt J; Qiu X; Lou SC; Pichlmayr R; Manns MP
    Hepatology; 1998 Aug; 28(2):379-84. PubMed ID: 9696000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of GB virus C/hepatitis G virus ribonucleic acid and anti-hepatitis G virus-E2 antibodies among Japanese children with histories of transfusions or with liver diseases.
    Goto K; Sugiyama K; Li R; Miyake Y; Ando T; Mizutani F; Terabe K; Mizuno K; Wada Y
    Pediatr Res; 1999 Jan; 45(1):128-32. PubMed ID: 9890620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and cellular immune responses to the GB virus C/hepatitis G virus envelope 2 protein.
    Lazdina U; Hultgren C; Chen M; Fischler B; Weiland O; Mushahwar IK; Sällberg M
    J Med Virol; 2000 Nov; 62(3):334-44. PubMed ID: 11055243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antienvelope antibodies are protective against GBV-C reinfection: evidence from the liver transplant model.
    Hassoba HM; Pessoa MG; Terrault NA; Lewis NJ; Hayden M; Hunt JC; Qiu X; Lou SC; Wright TL
    J Med Virol; 1998 Nov; 56(3):253-8. PubMed ID: 9783694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GB virus C (GBV-C/HGV) and E2 antibodies in children preliver and postliver transplant.
    Elkayam O; Hassoba HM; Ferrell LD; Garcia-Kennedy R; Gish RG; Wright TL; Laffler T; Traylor D; Hunt G; Rosenthal P
    Pediatr Res; 1999 Jun; 45(6):795-8. PubMed ID: 10367767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serological and molecular epidemiology of GB virus C/hepatitis G virus infection in a hepatitis C and B endemic area.
    Yu ML; Chuang WL; Dai CY; Lu SN; Wang JH; Huang JF; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY
    J Infect; 2001 Jan; 42(1):61-6. PubMed ID: 11243756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa.
    Sathar MA; Soni PN; Naicker S; Conradie J; Lockhat F; Gouws E
    J Med Virol; 1999 Sep; 59(1):38-44. PubMed ID: 10440806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a cell line constitutively expressing E2 glycoprotein of hepatitis C virus and humoral response of hepatitis C patients to the expressed protein.
    Harada S; Suzuki R; Ando A; Watanabe Y; Yagi S; Miyamura T; Saito I
    J Gen Virol; 1995 May; 76 ( Pt 5)():1223-31. PubMed ID: 7730806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ELISA for detection of antibody to the E2 protein of GB virus C.
    Gutierrez RA; Dawson GJ; Mushahwar IK
    J Virol Methods; 1997 Dec; 69(1-2):1-6. PubMed ID: 9504745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GB virus C (GBV-C) / hepatitis G virus (HGV): towards the design of synthetic peptides-based biosensors for immunodiagnosis of GBV-C/HGV infection.
    Rojo N; Ercilla G; Haro I
    Curr Protein Pept Sci; 2003 Aug; 4(4):291-8. PubMed ID: 14529536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequencies of GB virus C/hepatitis G virus genomes and of specific antibodies in German risk and non-risk populations.
    Nübling CM; Bialleck H; Fürsch AJ; Scharrer I; Schramm W; Seifried E; Schmidt U; Staszewski S; Löwer J
    J Med Virol; 1997 Nov; 53(3):218-24. PubMed ID: 9365885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure.
    Bourlet T; Guglielminotti C; Evrard M; Berthelot P; Grattard F; Frésard A; Lucht FR; Pozzetto B
    J Med Virol; 1999 Aug; 58(4):373-7. PubMed ID: 10421404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoassays to study prevalence of antibody against GB virus C in blood donors.
    Lou S; Qiu X; Tegtmeier G; Leitza S; Brackett J; Cousineau K; Varma A; Seballos H; Kundu S; Kuemmerle S; Hunt JC
    J Virol Methods; 1997 Oct; 68(1):45-55. PubMed ID: 9395139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of GBV-C/HGV-RNA, virus genotypes, and anti-E2 antibodies in autoimmune hepatitis.
    Tribl B; Schöniger-Hekele M; Petermann D; Bakos S; Penner E; Müller C
    Am J Gastroenterol; 1999 Nov; 94(11):3336-40. PubMed ID: 10566740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antibodies to E2-protein of GB virus-C/hepatitis G virus in patients with acute posttransfusion hepatitis.
    Hwang SJ; Lu RH; Chan CY; Chang FY; Lee SD
    J Med Virol; 1999 Jan; 57(1):85-9. PubMed ID: 9890427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.